Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices.

liver fibrosis liver stiffness shear wave elastography transient elastography ultrasound devices

Journal

Hepatology research : the official journal of the Japan Society of Hepatology
ISSN: 1386-6346
Titre abrégé: Hepatol Res
Pays: Netherlands
ID NLM: 9711801

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 03 04 2018
revised: 06 01 2019
accepted: 22 01 2019
pubmed: 27 1 2019
medline: 27 1 2019
entrez: 26 1 2019
Statut: ppublish

Résumé

Transient elastography (TE) is the gold standard for measurement of liver stiffness. The usefulness of shear wave elastographies (SWE) is well accepted. However, the measurement values cannot be equivalently compared because cut-off values for the diagnosis of liver fibrosis are different among those devices. We aimed to clarify correlations, to generate the regression equations between TE and SWEs, and to compare the diagnostic ability of each device to diagnose liver fibrosis. A total of 109 patients with chronic liver disease who underwent liver biopsy and same-day evaluation of liver stiffness using six ultrasound devices were analyzed. The diagnostic ability of liver stiffness from each ultrasound device and correlations between TE and each SWE were analyzed. Liver stiffness measured by all six ultrasound devices increased significantly as liver fibrosis stage advanced (P < 0.001). Receiver operating characteristic (ROC) curve analysis for predicting significant fibrosis (≥F2) and cirrhosis yielded area under the ROC curve (AUROC) values based on TE of 0.830 (95% confidence interval [CI], 0.755-0.905) and 0.959 (95% CI, 0.924-0.995), respectively. The AUROCs for predicting significant fibrosis (≥F2) and cirrhosis (F4) based on SWE from all five ultrasound devices were over 0.8 and 0.9, respectively. Furthermore, the correlation coefficients between TE values and SWE values from five ultrasound devices were all over 0.8, indicating a strong relationship. Our study showed strong correlations between TE and SWEs with high correlation coefficients. The regression equations between TE and SWEs demonstrated the ability to compare the measurement values in each device equivalently.

Identifiants

pubmed: 30680865
doi: 10.1111/hepr.13319
doi:

Types de publication

Journal Article

Langues

eng

Pagination

676-686

Subventions

Organisme : Japan Society for the Promotion of Science KAKENHI
ID : JP15K09029
Organisme : Japan Agency for Medical Research and Development
ID : JP17fk0210106

Informations de copyright

© 2019 The Japan Society of Hepatology.

Auteurs

Hiroko Iijima (H)

Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Toshifumi Tada (T)

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

Takashi Kumada (T)

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

Natsuko Kobayashi (N)

Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Masahiro Yoshida (M)

Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Tomoko Aoki (T)

Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Takashi Nishimura (T)

Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Chikage Nakano (C)

Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Akio Ishii (A)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Tomoyuki Takashima (T)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Yoshiyuki Sakai (Y)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Nobuhiro Aizawa (N)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Hiroki Nishikawa (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Naoto Ikeda (N)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Yoshinori Iwata (Y)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Hirayuki Enomoto (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Yoshi-Hiro Ide (YH)

Department of Surgical Pathology, Nishinomiya, Hyogo, Japan.

Seiichi Hirota (S)

Department of Surgical Pathology, Nishinomiya, Hyogo, Japan.

Jiro Fujimoto (J)

Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Shuhei Nishiguchi (S)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Classifications MeSH